As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...

With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is ...

S&P Global expects inflation to remain closer to 3.0% in 2025 as tariffs result in higher prices along the domestic supply ...

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

This adaptability and innovation can fuel revenue growth, says Ikeda. Furthermore, the analyst highlighted the promising growth potential of Datadog, Inc. (NASDAQ:DDOG)’s Flex Logs, which ...

With businesses seeking AI-powered solutions in a bid to improve efficiency and decision-making, ServiceNow, Inc. (NYSE:NOW)’s expanded AI capabilities can fuel strong growth and market share gains.

As one of the best pharmaceutical stocks focused on innovative pain therapies, Pacira is positioning itself for long-term growth. While SG&A expenses increased due to investments in commercial and ...

As the company drives leverage from its scale and witnesses benefits from AI-related efficiency initiatives, it delivered profitable growth. For Q3 2025, Palo Alto Networks, Inc. (NASDAQ ...

AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology ...

Here is what the fund said: “Two software stocks that the Fund did not own, Palantir Technologies Inc. (NASDAQ:PLTR) and AppLovin Corporation, each gained more than 100% and accounted for 52% ...

The analyst’s rating is backed by a combination of factors demonstrating the company’s growth potential and market position. As per the analyst, looking ahead, the potential market for ...